JACQUELYN JOHNSTON: Open Payments
NPI 1316385271 · NEWTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 29 payments from 16 companies in 2025. Trend: 2023 $516 · 2024 $321 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $93 |
| Lundbeck LLC | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $28 |
| Corium, LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: REXULTI, VRAYLAR, COBENFY, UZEDY, SPRAVATO, Azstarys, CAPLYTA, AUSTEDO XR.
Industry payments across IA — which companies pay providers there.
